X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1070) 1070
Publication (95) 95
Book / eBook (10) 10
Magazine Article (4) 4
Book Review (3) 3
Conference Proceeding (2) 2
Book Chapter (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
hyperkinesis - chemically induced (932) 932
animals (759) 759
male (740) 740
humans (495) 495
rats (459) 459
neurosciences (355) 355
female (342) 342
motor activity - drug effects (280) 280
mice (279) 279
index medicus (268) 268
pharmacology & pharmacy (228) 228
hyperkinesis - drug therapy (224) 224
dose-response relationship, drug (220) 220
behavior, animal - drug effects (186) 186
child (168) 168
hyperkinesis - physiopathology (164) 164
rats, sprague-dawley (161) 161
disease models, animal (140) 140
psychiatry (126) 126
time factors (123) 123
dopamine (122) 122
rats, wistar (120) 120
amphetamine (118) 118
hyperactivity (110) 110
schizophrenia (109) 109
hyperkinesis - metabolism (103) 103
locomotor activity (98) 98
dopamine - metabolism (93) 93
brain - metabolism (90) 90
brain (88) 88
child, preschool (85) 85
brain - drug effects (84) 84
pregnancy (82) 82
rat (78) 78
behavioral sciences (76) 76
nucleus-accumbens (76) 76
adult (74) 74
cocaine (72) 72
clinical neurology (70) 70
mice, inbred c57bl (70) 70
analysis of variance (68) 68
hyperkinesis - prevention & control (68) 68
article (67) 67
behavior (66) 66
amphetamine - pharmacology (65) 65
drug interactions (63) 63
animals, newborn (61) 61
locomotor-activity (61) 61
middle aged (61) 61
hyperkinesis - psychology (60) 60
adolescent (59) 59
antipsychotic agents - pharmacology (55) 55
central nervous system stimulants - pharmacology (55) 55
motor activity - physiology (53) 53
serotonin (51) 51
analysis (50) 50
age factors (49) 49
toxicology (47) 47
hippocampus - drug effects (46) 46
behavior, animal - physiology (45) 45
rats, inbred strains (45) 45
locomotion - drug effects (44) 44
serotonin - metabolism (43) 43
cocaine - pharmacology (42) 42
excitatory amino acid antagonists - pharmacology (42) 42
methamphetamine (42) 42
stereotyped behavior - drug effects (42) 42
expression (41) 41
neurons (41) 41
nucleus accumbens - drug effects (41) 41
prefrontal cortex (41) 41
behavioral sensitization (40) 40
schizophrenia - drug therapy (40) 40
dopamine agonists - pharmacology (39) 39
food additives - adverse effects (39) 39
mice, knockout (39) 39
rodents (39) 39
aged (38) 38
locomotion (38) 38
parkinson disease - drug therapy (38) 38
phencyclidine (38) 38
sensitization (38) 38
exploratory behavior - drug effects (37) 37
glutamate (37) 37
hippocampus (37) 37
prepulse inhibition (37) 37
children (36) 36
corpus striatum - drug effects (36) 36
neurons - drug effects (36) 36
receptors (36) 36
dextroamphetamine - pharmacology (35) 35
dopamine antagonists - pharmacology (35) 35
hyperkinesis - genetics (35) 35
in-vivo (35) 35
hyperkinesis (34) 34
mk-801 (33) 33
body weight - drug effects (32) 32
clinical trials as topic (32) 32
drug synergism (32) 32
haloperidol - pharmacology (31) 31
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (981) 981
German (43) 43
Russian (20) 20
Japanese (12) 12
French (7) 7
Italian (4) 4
Polish (4) 4
Swedish (4) 4
Spanish (3) 3
Chinese (2) 2
Czech (1) 1
Danish (1) 1
Finnish (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Brain, ISSN 0006-8950, 2004, Volume 127, Issue 9, pp. 2039 - 2054
Journal Article
Neuropharmacology, ISSN 0028-3908, 02/2017, Volume 113, Issue Pt A, pp. 71 - 81
Autism spectrum disorder (ASD) is an immensely challenging developmental disorder characterized primarily by two core behavioral symptoms of social... 
E/I imbalance | Valproic acid | NMDA receptor | Agmatine | Autism spectrum disorder | Therapeutics | SPONTANEOUSLY HYPERTENSIVE-RAT | DEFICIT HYPERACTIVITY DISORDER | SPECTRUM DISORDERS | POTENTIAL MECHANISM | NEUROSCIENCES | GLUTAMATERGIC NEURONAL DIFFERENTIATION | PREFRONTAL CORTEX | ATTENTION-DEFICIT/HYPERACTIVITY DISORDER | NITRIC-OXIDE PRODUCTION | FRAGILE-X-SYNDROME | PHARMACOLOGY & PHARMACY | GAMMA OSCILLATIONS | Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors | Seizures - prevention & control | Male | Agmatine - administration & dosage | Hippocampus - drug effects | Seizures - chemically induced | Hyperkinesis - prevention & control | Prefrontal Cortex - drug effects | Social Behavior | Neurons - metabolism | Valproic Acid | Neurons - drug effects | Disease Models, Animal | Grooming - drug effects | Neural Stem Cells - drug effects | Autism Spectrum Disorder - chemically induced | Rats | Mice, Transgenic | Rats, Sprague-Dawley | Agmatine - therapeutic use | Hippocampus - metabolism | Animals | MAP Kinase Signaling System - drug effects | Autism Spectrum Disorder - metabolism | Prefrontal Cortex - metabolism | Mice | Autism Spectrum Disorder - drug therapy | Primary Cell Culture | Neural Stem Cells - metabolism | Medical colleges | Autism | Divalproex | Neurosciences | Neural circuitry | Neurons | Analysis | GABA | Social aspects
Journal Article
Journal Article
Toxicology Letters, ISSN 0378-4274, 02/2014, Volume 225, Issue 1, pp. 78 - 85
Lead (Pb) exposure was commonly considered as a high environmental risk factor for the development of attention-deficit/hyperactivity disorder (ADHD). However,... 
Histone acetylation | Epigenetic | Lead (Pb) | Hyperactivity | ADHD | ACETYLATION | P300 | ATTENTION-DEFICIT/HYPERACTIVITY DISORDER | IN-VIVO | DISEASE | GENE-EXPRESSION | NEURONS | TOXICOLOGY | BLOOD LEAD | INFLAMMATORY RESPONSE | Dopamine Plasma Membrane Transport Proteins - metabolism | Attention Deficit Disorder with Hyperactivity - physiopathology | Hyperkinesis - genetics | Prenatal Exposure Delayed Effects | Age Factors | Receptors, Dopamine D4 - drug effects | Lead Poisoning, Nervous System, Childhood - metabolism | Motor Activity - drug effects | Male | Hyperkinesis - physiopathology | Hippocampus - drug effects | Hyperkinesis - metabolism | RNA, Messenger - metabolism | Gene-Environment Interaction | Maternal Exposure | Dose-Response Relationship, Drug | Attention Deficit Disorder with Hyperactivity - metabolism | Protein Processing, Post-Translational - drug effects | p300-CBP Transcription Factors - genetics | Behavior, Animal - drug effects | Female | Lead Poisoning, Nervous System, Childhood - etiology | Epigenesis, Genetic - drug effects | Hyperkinesis - chemically induced | Acetylation | Lead Poisoning, Nervous System, Childhood - psychology | Lead Poisoning, Nervous System, Childhood - physiopathology | Attention Deficit Disorder with Hyperactivity - chemically induced | Organometallic Compounds - toxicity | Rats | Lead Poisoning, Nervous System, Childhood - genetics | Rats, Sprague-Dawley | Pregnancy | Hippocampus - metabolism | p300-CBP Transcription Factors - metabolism | Animals | Attention Deficit Disorder with Hyperactivity - genetics | Hyperkinesis - psychology | Attention Deficit Disorder with Hyperactivity - psychology | Receptors, Dopamine D4 - metabolism | Histones - metabolism | Hippocampus - physiopathology | Proteins | Index Medicus
Journal Article
Genes, Brain and Behavior, ISSN 1601-1848, 03/2019, Volume 18, Issue 3, pp. e12528 - n/a
The atypical vesicular glutamate transporter VGLUT3 is present in subpopulations of GABAergic interneurons in the cortex and the hippocampus, in subgroups of... 
DBA2 | 129Sv | anxiety | vesicular glutamate transporter (VGLUT3) | C3H, C57Bl6/N | locomotion | BALB/c | LOCOMOTOR-ACTIVITY | KNOCKOUT MICE | C57BL/6J | REWARD | NEUROSCIENCES | INTRAVENOUS COCAINE | VESICULAR GLUTAMATE TRANSPORTERS | MUTATION | <